Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Lems

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Rehabilitation Medicine|September 21, 2017
Proprioception mediates the association between systemic inflammation and muscle weakness in patients with knee osteoarthritis: Results from the Amsterdam Osteoarthritis cohortTomasz Cudejko, Martin van der Esch, Marike van der Leeden, et al.
Journal of Rehabilitation Medicine|November 30, 2017
Factors associated with upper leg muscle strength in knee osteoarthritis: A scoping reviewArjan H de Zwart, Joost Dekker, Willem Lems, et al.
Arthritis and Rheumatism|May 18, 2004
Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritisRobert Landewé, Piet Geusens, Maarten Boers, et al.
RMD Open|April 30, 2024
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt studyJoy Ardjuna van der Pol, Cornelia F Allaart, Willem Lems, et al.
Calcified Tissue International|January 23, 2022
Bone Involvement in Patients with SpondyloarthropathiesWillem Lems, Corinne Miceli-Richard, Judith Haschka, et al.
Bone|July 28, 2025
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS)Anda Mihaela Naciu, Gaia Tabacco, Andrea Palermo, et al.
Arthritis and Rheumatism|March 2, 2006
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritisGerrit Jan Wolbink, Marijn Vis, Willem Lems, et al.
Annals of the Rheumatic Diseases|April 23, 2013
A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeksDebby den Uyl, Marieke ter Wee, Maarten Boers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 18, 2021
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With GlucocorticoidsKenneth G Saag, Michele T McDermott, Jonathan Adachi, et al.
RMD Open|February 12, 2022
Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PETNicki Verweij, Gerben Zwezerijnen, Marieke Ter Wee, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Rehabilitation Medicine|September 21, 2017
Proprioception mediates the association between systemic inflammation and muscle weakness in patients with knee osteoarthritis: Results from the Amsterdam Osteoarthritis cohortTomasz Cudejko, Martin van der Esch, Marike van der Leeden, et al.
Journal of Rehabilitation Medicine|November 30, 2017
Factors associated with upper leg muscle strength in knee osteoarthritis: A scoping reviewArjan H de Zwart, Joost Dekker, Willem Lems, et al.
Arthritis and Rheumatism|May 18, 2004
Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritisRobert Landewé, Piet Geusens, Maarten Boers, et al.
RMD Open|April 30, 2024
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt studyJoy Ardjuna van der Pol, Cornelia F Allaart, Willem Lems, et al.
Calcified Tissue International|January 23, 2022
Bone Involvement in Patients with SpondyloarthropathiesWillem Lems, Corinne Miceli-Richard, Judith Haschka, et al.
Bone|July 28, 2025
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS)Anda Mihaela Naciu, Gaia Tabacco, Andrea Palermo, et al.
Arthritis and Rheumatism|March 2, 2006
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritisGerrit Jan Wolbink, Marijn Vis, Willem Lems, et al.
Annals of the Rheumatic Diseases|April 23, 2013
A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeksDebby den Uyl, Marieke ter Wee, Maarten Boers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 18, 2021
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With GlucocorticoidsKenneth G Saag, Michele T McDermott, Jonathan Adachi, et al.
RMD Open|February 12, 2022
Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PETNicki Verweij, Gerben Zwezerijnen, Marieke Ter Wee, et al.
Pageof 4